The four indicators are: primary care consultations (30% weight, 100% target), laboratory utilization (30% weight, 50% target), antibiotics dispensing for communicable disease (10% weight, 15% target), and NCD medicines dispensing (30% weight, 20% target). Together they form your performance factor — the multiplier that decides how much of the P1,020-per-beneficiary second tranche your clinic actually receives.
Under PhilHealth Circular No. 2024-0013, Annex I, the YAKAP (formerly Konsulta) capitation is a maximum of P1,700 per registered beneficiary per year. The first 40% — P680 — is paid monthly for every validated First Patient Encounter (FPE). The remaining 60% — up to P1,020 — is paid at year end, and it is not automatic. It is scaled by your performance factor. A clinic that registers thousands of beneficiaries but never sees them again gets a performance factor near zero, and near-zero second-tranche income. (For the full capitation structure, see The P1,700 YAKAP Capitation, Fully Explained.)
The 4 Indicators, Their Targets, and Their Weights
Each indicator is a ratio: unique beneficiaries who received the service, divided by your registered beneficiaries with validated FPE. That ratio is divided by the indicator's target, then multiplied by its weight. The sum of the four weighted scores is your performance factor.
- Primary Care Consultation — unique beneficiaries who consulted a primary care doctor. Target: 100%. Weight: 30%.
- Utilization of Laboratory Services — unique individuals who received a laboratory service. Target: 50%. Weight: 30%.
- Dispensing of Medicines for Communicable Diseases — unique beneficiaries who received antibiotics as prescribed by their primary care doctor. Target: 15%. Weight: 10%.
- Dispensing of NCD Medicines — unique beneficiaries who received non-communicable disease medication as prescribed. Target: 20%. Weight: 30%.
The weights sum to 100%. Three things follow directly from this table:
- Consultations, labs, and NCD medicines each carry triple the weight of antibiotics. That is where your effort pays.
- The targets are ratios of your FPE base. Every FPE you register raises the denominator of all four indicators — registration without follow-through actively dilutes your score.
- "Unique beneficiaries" means one patient consulted five times counts once. Breadth across your panel beats depth on a few patients.
The Worked Example: How a Real Score Is Computed
Annex I's own sample clinic — 14,850 registered beneficiaries with validated FPE — scores a performance factor of 0.52, or 52%. The component math:
- Consultations: 8,000 of 14,850 consulted (about 54%). Divided by the 100% target and weighted at 30%, this contributes about 16%.
- Laboratories: 3,000 of 14,850 received a lab service (about 20%). Against the 50% target, weighted 30%, this contributes about 12%.
- Antibiotics: 2,000 of 14,850 (about 13.5%). Against the 15% target, weighted 10%, this contributes about 9%.
- NCD medicines: 1,500 of 14,850 (about 10%). Against the 20% target, weighted 30%, this contributes about 15%.
Sum: 16% + 12% + 9% + 15% = 52%.
What 52% Costs You in Pesos
The second tranche formula in Annex I is: registered beneficiaries with validated FPE × performance factor × P1,020.
- Sample public clinic: 14,850 × 0.52 × P1,020 = P7,876,440.
- Sample private clinic: the same, minus the 2% withholding tax on private facilities — P7,876,440 − P157,528.80 = P7,718,911.20.
- At a 100% performance factor, that same panel would earn 14,850 × P1,020 = P15,147,000. The 52% score left roughly P7.27 million unearned.
Scaled down: for a clinic with 1,000 FPEs, every single percentage point of performance factor is worth P10,200 of second tranche. Moving from 52% to 70% is worth about P183,600 on that panel.
How to Keep Each Indicator High
The strategy for each indicator follows from its weight and target:
- Consultations (30%, target 100%): the hardest target and a top weight. The FPE is explicitly not a medical consultation — a beneficiary who only completes FPE contributes zero here. Convert every FPE into a booked consultation before the patient leaves; recall unconsulted beneficiaries in Q3–Q4, not December.
- Laboratories (30%, target 50%): you only need half your panel to receive one lab service. Bundle age- and sex-appropriate diagnostics into the first consultation so the lab encounter happens in the same visit.
- Antibiotics (10%, target 15%): the lowest weight and a target you may hit incidentally through normal acute care. Never over-prescribe to chase it — the encoding of legitimately dispensed antibiotics matters more than volume.
- NCD medicines (30%, target 20%): high weight, modest target. Your hypertensive and diabetic patients on maintenance medication (amlodipine, metformin, losartan under the GAMOT schedule) are the backbone of this indicator — dispense, record, and refill them through the clinic.
Two cross-cutting rules. First, every encounter must be encoded and transmitted: Annex I requires XML submission preferably daily, and second-tranche data must be complete by end of January of the succeeding year — services rendered but not uploaded score zero. Second, every encounter needs its compliance trail: since January 1, 2026, PhilHealth Advisory 2025-0072 requires a PCU liveness-check transaction number and a signed MCA/YES on SAP 1 submissions, and PhilHealth conducts post-audit reviews. An unverifiable encounter is worse than no encounter — it can trigger payment recovery. If your remittances already look thinner than the formula predicts, see Why YAKAP Clinics Get Paid Less Than Expected, and for the calendar of cutoffs, Tranche 1 vs Tranche 2 Timelines.
How RecordKo Keeps Your Performance Factor Visible All Year
RecordKo is built for YAKAP end-to-end: the FPE and reception-to-doctor consultation workflow captures PCU liveness results and transaction numbers on every encounter, SOAP consultations generate eKAS and ePresS slips with the GAMOT medicine list built in, labs and dispensed medicines are encoded onto the correct consultation record, and claims go out as validated, encrypted XML. A performance-indicator dashboard tracks all four ratios against their targets in real time — so you find your consultation gap in August, not in the January SAP2 ledger. Designed for the certified-EMR era, with XML batch import for clinics migrating from eKonsulta or other systems.
References
- PhilHealth Circular No. 2024-0013, Annex I: Approved Benefit Payment and Co-Payment Schedule with Sample Computation
- PhilHealth Circular No. 2025-0017: Selection and Empanelment for PhilHealth's Primary Care Benefit Package
- PhilHealth Advisory No. 2025-0072: PCU Liveness Check and YAKAP Empanelment Slip Required for SAP 1 Payment